CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,352,481 | +518.5% | 158,157 | +662.6% | 0.00% | – |
Q2 2023 | $703,708 | +28954.8% | 20,740 | -61.8% | 0.00% | -100.0% |
Q4 2022 | $2,422 | -100.0% | 54,351 | -79.1% | 0.00% | -75.0% |
Q2 2022 | $6,998,000 | +90.8% | 259,543 | +141.0% | 0.00% | +100.0% |
Q1 2022 | $3,668,000 | +139.3% | 107,701 | +171.5% | 0.00% | +100.0% |
Q4 2021 | $1,533,000 | -85.3% | 39,671 | -92.1% | 0.00% | -85.7% |
Q1 2021 | $10,406,000 | +188.4% | 505,163 | +145.3% | 0.01% | +133.3% |
Q4 2020 | $3,608,000 | -39.9% | 205,922 | -55.4% | 0.00% | -66.7% |
Q2 2020 | $6,003,000 | – | 461,764 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |